Trials / Conditions / Ovarian Adenocarcinoma

Ovarian Adenocarcinoma

11 registered clinical trials studyying Ovarian Adenocarcinoma — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Red NCT07429487	Centre Antoine Lacassagne	N/A
Recruiting	Anatomopathological Analysis of the Infundibulopelvic Ligament in Patients With Ovarian Cancer NCT07100288	Complejo Hospitalario Universitario Insular Materno Infantil	—
Active Not Recruiting	A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer NCT05451849	TCR2 Therapeutics	Phase 1 / Phase 2
Terminated	A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) NCT05001282	Elucida Oncology	Phase 1 / Phase 2
Completed	CINSARC Genomic Signature as Predictor of Resectability of Ovarian Adenocarcinoma NCT04248231	Institut Claudius Regaud	—
Terminated	The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors NCT03641287	University of Washington	N/A
Completed	PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies NCT03365791	Novartis Pharmaceuticals	Phase 2
Terminated	Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, F NCT02923739	M.D. Anderson Cancer Center	Phase 2
Active Not Recruiting	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors NCT02834013	National Cancer Institute (NCI)	Phase 2
Completed	Dose Escalation of Cisplatin Hyperthermic Intraperitoneal Chemotherapy After Surgery in Patients With Unresect NCT02217956	Gustave Roussy, Cancer Campus, Grand Paris	Phase 1
Terminated	YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal NCT00899093	Gynecologic Oncology Group	—